跳至主要内容
临床试验/NCT01616069
NCT01616069已完成4 期

Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using Intraoperative Transesophegeal Echocardiography

Federal University of Juiz de Fora1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
81
试验地点
1
主要终点
Systolic and diastolic heart function

研究概览

简要总结

This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sinusal ritmus
  • EF > 35%
  • Elective CABG surgery

排除标准

  • No accept
  • Severe valvular regurgitation or stenoses
  • Chest pain
  • Cardiogenic shock

研究组 & 干预措施

epinephrine

Active Comparator

Assessment of systolic and diastolic heart function during CABAG with CPB with levosimendan using TEE.

干预措施: epinephrine and levosimendan (Drug)

levosimendan

Active Comparator

Assessment of systolic and diastolic heart function during CABAG with CPB with epinephrine using TEE.

干预措施: epinephrine and levosimendan (Drug)

结局指标

主要结局

Systolic and diastolic heart function

时间窗: Two years

Assessment the systolic and diastolic heart function

次要结局

  • Mortality after CABAG(Two years)

研究者

发起方
Federal University of Juiz de Fora
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marcello F Salgado Filho, MD

Principal investigator

Universidade Federal do Rio de Janeiro

研究点 (1)

Loading locations...

相似试验